ESC Premium Access

Introduction - Targeting SGLT2 in clinical cardiology: discussing the benefits in cardiovascular risk, diabetes & heart failure.

Topic: Diabetes and the Heart
Organised by PACE-CME, Physicians' Academy for Cardiovascular Education, supported with an educational grant from Boehringer Ingelheim/Lilly

Congress Presentation

About the speaker

Professor Francesco Cosentino

Karolinska University Hospital, Stockholm (Sweden)
25 presentations
0 follower

2 more presentations in this session

Targeting SGLT2 inhibition in cardiology: what is the profile of benefit?

Speaker: Professor N. Marx (Aachen, DE)

Thumbnail

Panel discussion: discussing the benefits in cardiovascular risk, diabetes & heart failure.

Speaker: Professor S. Jacob (Villingen, DE) Professor N. Marx (Aachen, DE) Professor F. Cosentino (Stockholm, SE) Professor J. Deanfield (London, GB)

Thumbnail

Access the full session

Targeting SGLT2 in clinical cardiology: discussing the benefits in cardiovascular risk, diabetes & heart failure

Speakers: Professor F. Cosentino, Professor N. Marx, Professor S. Jacob, Professor N. Marx, Professor F. Cosentino...
Thumbnail

About the event

Image

ESC Congress 2018

7 November - 29 August 2018

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb